Results

Total Results: 2,080 records

Showing results for "drug".

1761. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
      January 01, 2021 - communication and cognitive problems, acute inflammation at the application site, knee joint surgery or drug … blind; pregnant, lactating, or that they anticipate becoming pregnant in the next 3 months; current drug

1762. Proposals for a Phased Evaluation of Medical Tests | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/medical-tests-proposals/research

1763. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
      May 01, 2012 - As part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Congress directed … Food and Drug Administration Division of Psychiatry Products Silver Spring, MD Stephen Faraone, … Such secondary data, however, may not be optimal for examination of drug benefits, which generally requires

1764. VTE Surveillance Assessment_49_low_SPI (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
      December 01, 2012 - The Food and Drug Administration (FDA), Health Canada, and Medicines and Healthcare products Regulatory … would produce prima facie evidence that a conclusion was out of date, such as the withdrawal of a drug … Uptodate CER=comparative effectiveness review; FDA=food and drug administration; NA=not applicable;

1765. Nppv-Respiratory-Failure Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_executive.pdf
      July 01, 2012 - Food and Drug Administration for any unpublished RCT data available for devices used to provide noninvasive … Food and Drug Administration; ICU = intensive care unit; KQ = Key Question; NPPV = noninvasive positive-pressure

1766. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
      October 01, 2016 - One RCT43 examined three possible harms: drug-related adverse effects; incidence of abnormal QT (QRS … flunitrazepam, no statistical testing reported (3 vs. 3, p=NR).48 Drug-related adverse events 91

1767. Disposition of Comments_Comparative Effectiveness Review No. 268: Impact of Healthcare Algorithms on Racial and Ethnic Disparities in Health and Healthcare (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-268-racial-disparities-health-healthcare-disposition-comments.pdf
      December 08, 2023 - Articles include other issues include drug impacts, for instance Warfin is not effective in African … Effect of removing race from GFR-estimating equations on anticancer drug dosing and eligibility: a

1768. Gout Executive-2016 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
      January 01, 2016 - Drug expenditures accounted for 61 percent of the total costs.2 In addition to gout, the types of … development of inflammation and pain, erythema, monoarthritis, response to administration of the drug

1769. Disposition of Comments for CER 196 The Role of Immunotherapy in the Treatment of Asthma (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-disposition-comments-immunotherapy-asthma.pdf
      March 23, 2018 - Drug Saf 2005; 28:1057-63) As you note, this information is not usually available in the manuscripts

1770. Disposition of Comments for Strategies To Prevent Weight Gain Among Adults (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_disposition-comments.pdf
      March 25, 2013 - We agree that a future research need is identifying the best tool to assess quality for non-drug/device

1771. new disposition of comments insulin analogues -- jda revs.xls (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
      September 01, 2008 - new disposition of comments insulin analogues -- jda revs.xls                                                                                                                                                Comment, by Section Response Executive Summary Comment: A statement under Gaps in Evidence and Future Direction…

1772. Disposition of Comments Report for Assessment and Management of Chronic Cough (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
      January 07, 2013 - Disposition of Comments Report for Assessment and Management of Chronic Cough Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1371 Published Online: January 7, 2013 Comparative Effectiveness Research Review Disposition of Comments Repor…

1773. Pressure-Ulcer-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
      May 01, 2013 - Scientific information packets (SIPs) were requested from identified drug and device manufacturers,

1774. Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/recombinant-factor-viia/research/

1775. Inguinal-Hernia Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/inguinal-hernia_executive.pdf
      August 01, 2012 - Food and Drug Administration, input from the Technical Expert Panel, and the consensus of the research

1776. Methods Guide for Medical Test Reviews Chapter 12 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
      July 01, 2012 - If a prognostic test has been submitted for review by regulatory agencies such as the Food and Drug

1777. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
      September 08, 2011 - Information Packets from the Scientific Resource Center and gray literature from conferences, the Food and Drug

1778. Template for Reports Developed (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
      October 26, 2012 - confirmed recurrence of CDI of any disease severity Novel therapy e.g., monoclonal antibody, drug … confirmed recurrence of CDI of any disease severity Novel therapy e.g., monoclonal antibody, drug

1779. Options for Developing a Web-Based Forum on Patient Registries (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
      May 01, 2014 - For a drug or device manufacturer, a registry-based study might demonstrate the performance of a product … Number 44 of Rheumatology, American Academy of Family Physicians), government (e.g., NIH, Food and Drug … networking at professional conferences, Webinar and working groups (e.g., those hosted by AHRQ and the Drug

1780. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
      December 23, 2009 - Confidence interval COAG Chronic open angle glaucoma EPC Evidence-based Practice Center FDA Food and Drug